Ebola Outbreak: Can We Control the Virus?

The World Health Organization (WHO) has acknowledged it is unable to control the Ebola virus outbreak in Uganda, according to Sözcü Gazetesi. The statement comes as the country reports 19 confirmed cases of the virus, with health officials expressing concerns over the rapid spread. "We are not in a position to control the outbreak," a WHO spokesperson said, citing challenges in containment efforts. The announcement follows a surge in cases since the start of 2026, raising alarms among public health authorities.

Confirmed cases and response efforts
Uganda’s Ministry of Health reported 19 Ebola cases as of June 10, 2026, with 12 deaths recorded, according to Anadolu Ajansı. The majority of cases have been concentrated in the western region, where contact tracing has proven difficult due to limited healthcare infrastructure. The WHO has deployed emergency teams to support local efforts, but officials say the virus is spreading faster than containment measures can address.

In the Democratic Republic of the Congo (DRC), where Ebola outbreaks have been frequent, similar challenges persist. A separate report from Haberler notes that while the DRC has maintained a vaccination program, cross-border transmission remains a risk. "The virus does not respect borders," said a DRC health official, referencing recent cases linked to travel between Uganda and the DRC.

Global health implications
The WHO’s admission highlights the growing difficulty in managing Ebola outbreaks in regions with weak healthcare systems. The agency has previously warned that delayed responses increase the risk of epidemic spread. In 2023, a 10-month Ebola outbreak in the DRC resulted in over 1,400 deaths, underscoring the challenges of controlling the virus in conflict-affected areas.

Public health experts emphasize that the current situation in Uganda is compounded by low vaccination coverage and community resistance. A 2025 study published in the Lancet found that misinformation about Ebola vaccines has reduced uptake in several African countries. "Without trust in health interventions, containment becomes nearly impossible," said Dr. Amina Jalloh, a virologist at the University of Nairobi.

Comparative context
The 19 cases in Uganda represent a significant increase from the 47 cases reported in the DRC during the same period in 2025. However, the fatality rate in Uganda remains lower, at 63%, compared to 68% in the DRC. Health officials attribute this to improved access to experimental treatments, including monoclonal antibody therapies.

The WHO has also faced criticism for its delayed response to the Ugandan outbreak. In 2024, the agency was accused of underestimating the risk of a new Ebola strain in West Africa, leading to a 20% increase in cases. A 2026 internal review cited "bureaucratic delays" as a key factor in the slow deployment of resources.

What remains uncertain
While the WHO has pledged additional funding for Uganda, the long-term effectiveness of containment measures is unclear. Health experts warn that the virus’s high mutation rate could lead to new variants resistant to existing vaccines. "We are playing catch-up," said Dr. Luisa Fontaine, a WHO epidemiologist. "Every day we delay, the virus evolves."

The agency has also called for international cooperation to address cross-border transmission. A joint meeting between Ugandan and DRC officials, reported by Kurdistan24, aimed to coordinate surveillance and vaccination campaigns. However, logistical challenges, including unstable border regions, remain a barrier.

Public health officials urge communities to prioritize hygiene and avoid contact with infected individuals. The WHO has distributed over 10,000 doses of the Ebola vaccine in Uganda, but distribution has been slow in remote areas. "We need more time, more resources, and more community engagement," said a local health worker in Mbarara, Uganda.

As the situation develops, the WHO has scheduled a press conference for June 12 to provide further updates. For now, the agency’s admission of limited control underscores the urgent need for global collaboration in combating infectious diseases.